Cell and Gene Therapy for Personalised Medicine (CGT4PM2027)
Cascade funding call (financial support to third parties) issued by the EU-funded project European Partnership for Personalised Medicine (EP PerMed), under topic HORIZON-HLTH-2023-CARE-08-01 European Partnership on Personalised Medicine.
With this JTC, EP PerMed will fund research projects in human health on Cell and Gene Therapies (CGT) for PM approaches. Proposals must focus on the development and validation of an innovative and novel CGT for PM.
At least one of the following approaches must be employed:
Somatic cell therapeutics;
Gene therapeutics;
Combined cell- and gene therapeutics;
Novel biological products.
For the entire scope, please consult the Call Text: https://www.eppermed.eu/funding-projects/calls/jtc2027/.
All information and documents concerning the EP PerMed Joint Transnational Call (JTC) 2027, including the call text outlining the aims and scope of the call, the Guidelines for Applicants document, the pre-proposal form, etc. can be found here: https://www.eppermed.eu/funding-projects/calls/jtc2027/.
Electronic submission system: https://ptoutline.eu/app/eppermed2027.
Deadline to submit pre-proposals: 20 January 2027 (14:00, CET)
Deadline to submit full proposals: 25 May 2027 (14:00, CEST)
Applicants should contact their corresponding regional/national representative to enquire about eligibility with their respective funding organisations prior to submitting an application (see regional/national contact details, Annex I of the call text). For additional information, please contact the JCS (EPPerMed@anr.fr). Adherence to the regional/national funding regulations in the “Guidelines for Applicants” document is mandatory (www.eppermed.eu).
Change history
First seen 14 Nov 2026, last checked 22 Nov 2026. 1 recorded version.
- 14 Nov 2026 · ab8528fa6bf4